Pediatric nasopharyngeal carcinoma: Anatomoclinic aspects, therapeutic results and evolutive particularities;Le cancer du cavum de l'enfant et l'adulte jeune : aspects anatomocliniques, thérapeutiques et particularités évolutives

Cancer/Radiotherapie

Volumn 14, Issue 3, 2010, Pages 169-175

  Frikha, M ^a   Toumi, N ^a   Ghorbel, L ^a   Ben Salah, H ^a   Khabir, A ^a   Karray, H ^a   Gargouri, R ^b   Boudawara, T ^a   Ghorbel, A ^a   Daoud, J ^a  

^a HABIB BOURGUIBA HOSPITAL   (Tunisia)

^b CENTRE DE BIOTECHNOLOGIE DE SFAX   (Tunisia)

Author keywords

Chemotherapy; Child; Nasopharyngeal carcinoma; Prognosis; Radiotherapy; Toxicity

Indexed keywords

CISPLATIN; FLUOROURACIL;

ADOLESCENT; ADULT; ADVANCED CANCER; ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER RELAPSE; CANCER SURVIVAL; CERVICAL LYMPH NODE; CHILD; DISEASE FREE SURVIVAL; DISTANT METASTASIS; ENDOCRINE DISEASE; FEMALE; FIBERSCOPE ENDOSCOPY; HUMAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; NASOPHARYNX CARCINOMA; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PRIORITY JOURNAL; RADIATION DOSE; RADIODENSITOMETRY; SURVIVAL RATE; TREATMENT RESPONSE; TUMOR BIOPSY; XEROSTOMIA;

ADOLESCENT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BLEOMYCIN; CARCINOMA; CHEMOTHERAPY, ADJUVANT; CHILD; CISPLATIN; COBALT RADIOISOTOPES; COMBINED MODALITY THERAPY; DISEASE-FREE SURVIVAL; EPIRUBICIN; FEMALE; FLUOROURACIL; FOLLOW-UP STUDIES; HUMANS; KAPLAN-MEIERS ESTIMATE; LYMPHATIC METASTASIS; MALE; NASOPHARYNGEAL NEOPLASMS; NEOADJUVANT THERAPY; NEOPLASM RECURRENCE, LOCAL; NEOPLASMS, RADIATION-INDUCED; NEOPLASMS, SECOND PRIMARY; RADIOISOTOPE TELETHERAPY; RADIOTHERAPY, CONFORMAL; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; XEROSTOMIA; YOUNG ADULT;

EID: 77952424620     PISSN: 12783218     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canrad.2010.01.003     Document Type: Article

References (30)

1. Al Sarraf M., Le Blanc M., Giri P.G., Fu K.K., Cooper J., Vuong T., et al. Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer: phase III randomized intergroup study 0099. J Clin Oncol 16 (1998) 1310-1317
2. Ayan I., Kaytan E., and Ayan N. Childhood nasopharyngeal carcinoma: From biology to treatment. Lancet Oncol 4 (2003) 13-21
3. Bonner J.A., Harari P.M., Giralt J., Azarnia N., Shin D.M., Cohen R.B., et al. Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck. N Engl J Med 354 (2006) 567-568
4. Chan A.T., Leung S.F., Ngan R.K., Teo P.M., Lau W.H., Kwan W.H., et al. Overall survival after concurrent cisplatin-radiotherapy compared with radiotherapy alone in locoregionally advanced nasopharyngeal carcinoma. J Natl Cancer Inst 97 (2005) 536-539
5. Chua D.T., Sham J.S., Choy D., Lorvidhaya V., Sumitsawan Y., Thongprasert S., et al. Preliminary report of the Asian-Oceanian Clinical Oncology Association randomized trial comparing cisplatin and epirubicin followed by radiotherapy versus radiotherapy alone in the treatment of patients with locoregionally advanced nasopharyngeal carcinoma. Asian-Oceanian clinical oncology association nasopharynx cancer study group. Cancer 83 (1998) 2270-2283
6. Daoud J., Siala W., Guermazi F., Besbes M., Frikha M., Ghorbel M., et al. Hypothyroïdie après irradiation cervicale dans le traitement des cancers du nasopharynx et du sein : étude prospective à propos de 84 patients. Cancer Radiother 9 (2005) 140-147
7. Daoud J., Toumi N., Bouaziz M., Ghorbel A., Jlidi R., Drira M.M., et al. Nasopharyngeal carcinoma in childhood and adolescence: analysis of a series of 32 patients treated with combined chemotherapy and radiotherapy. Eur J Cancer 39 (2003) 2349-2354
8. Daoud J., Toumi N., Siala W., Ghorbel A., Drira M.M., and Frikha M. Results of a prospective randomised trial comparing conventional radiotherapy to split course bifractionated radiation therapy in patients with nasopharyngeal carcinoma. Radiother Oncol 85 (2007) 17-23
9. Fang F.M., Tsai W.L., Chen H.C., Hsu H.C., Hsiung C.Y., Chien C.Y., et al. Intensity-modulated or conformal radiotherapy improves the quality of life of patients with nasopharyngeal carcinoma: comparisons of four radiotherapy techniques. Cancer 109 (2007) 313-321
10. Fu K.K., Pajak T.F., Trotti A., Jones C.U., Spencer S.A., Phillips T.L., et al. A radiation therapy oncology group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinoma: first report of RTOG 9003. Int J Radiat Oncol Biol Phys 48 (2000) 7-16
11. Habrand J., Guillot Valls D.G., Petras S., Le Deley M., and Patte C. Carcinoma of the nasopharynx in children and adolescents treated with initial chemotherapy followed by adapted doses of radiotherapy. In: Proceedings of the 46th annual ASTRO meeting. Int J Radiat Oncol Biol Phys (2004) S247
12. Jmal A., Boussen H., Ghanem A., Abaza H., Gara S., Douik H., et al. Le carcinome nasopharyngé chez l'enfant tunisien, étude rétrospective épidémiologique, clinique et biologique : à propos de 48 cas. Bull Cancer 92 (2005) 977-981
13. Laskar S., Sanghavi V., Muckaden M.A., Ghosh S., Bhalla V., Banavali S., et al. Nasopharyngeal carcinoma in children: 10 years' experience at the Tata Memorial Hospital, Mumbai. Int J Radiat Oncol Biol Phys 58 (2004) 189-195
14. Leseur J., Carrie C., Le Prisé E., Bernier V., Beneyton V., Mahé M.A., et al. Radiothérapie conformationnelle par modulation d'intensité des tumeurs pédiatriques. Cancer Radiother 13 (2009) 536-542
15. Louis C.U., Paulino A.C., Gottschalk S., Bertuch A.A., Chintagumpala M., Heslop H.E., et al. A single institution experience with pediatric nasopharyngeal carcinoma: high incidence of toxicity associated with platinum-based chemotherapy plus IMRT. J Pediatr Hematol Oncol 29 (2007) 500-505
16. Ma B.B., and Chan A.T. Recent perspectives in the role of chemotherapy in the management of advanced nasopharyngeal carcinoma. Cancer 103 (2005) 22-31
17. Maalej M., Ben Ammar C., Kochbati L., Frikha H., Hentati D., Gargouri W., et al. Curiethérapie endocavitaire par brachythérapie dans le cancer du nasopharynx : technique de traitement et résultats. Cancer Radiother 11 (2007) 117-121
18. Mertens R., Granzen B., Lassay L., Bucsky P., Hundgen M., Stetter G., et al. Treatment of nasopharyngeal carcinoma in children and adolescents: definitive results of a multicenter study (NPC-91-GPOH). Cancer 104 (2005) 1083-1089
19. Nakamura R.A., Novaes P.E., Antoneli C.B., Fogaroli R.C., Pellizzon A.C., Ferrigno R., et al. High dose-rate brachytherapy as part of a multidisciplinary treatment of nasopharyngeal lymphoepithelioma in childhood. Cancer 104 (2005) 525-531
20. Nasr Ben Ammar C., Chaari N., Kochbati L., Attia I., Ben Hamadi D., Chebbi A., et al. Radionécrose cérébrale chez les patients irradiés pour cancer du nasopharynx : à propos de neuf cas. Cancer Radiother 11 (2007) 234-240
21. Noël G., Dessard-Diana B., Vignot S., and Mazeron J.J. Les traitements des cancers du nasopharynx : revue de la littérature. Cancer Radiother 6 (2002) 59-84
22. Orbach D., Brisse H., Helfre S., Klijanienko J., Bours D., Mosseri V., et al. Radiation and chemotherapy combination for nasopharyngeal carcinoma in children: Radiotherapy dose adaptation after chemotherapy response to minimize late effects. Pediatr Blood Cancer 50 (2008) 849-853
23. Ozyar E., Selek U., Laskar S., Uzel O., Anacak Y., Ben-Arush M., et al. Treatment results of 165 pediatric patients with non-metastaticnasopharyngeal carcinoma: A rare cancer network study. Radiother Oncol 81 (2006) 39-46
24. Posner M.R., Hershock D.M., Blajman C.R., Mickiewicz E., Winquist E., and Gorbounova V. Cisplatin and fluorouracil alone or with docetaxel in head and neck cancer. N Engl J Med 357 (2007) 1705-1715
25. Preliminary results of a randomized trial comparing neoadjuvant chemotherapy (cisplatin, epirubicin, bleomycin) plus radiotherapy versus radiotherapy alone in stage IV (> or = N2, M0) undifferentiated nasopharyngeal carcinoma: a positive effect on progression-free survival. International Nasopharynx Cancer Study Group. VUMCA I trial. Int J Radiat Oncol Biol Phys 1996;35:463-9.
26. Siala W., Mnejja W., Khabir A., Ben Mahfoudh K., Boudawara T., Ghorbel A., et al. Toxicité neurologique tardive après traitement des carcinomes nasopharyngés. Cancer Radiother 13 (2009) 709-714
27. Teo P.M., Leung S.F., Chan A.T., Leung T.W., Choi P.H., Kwan W.H., et al. Final report of a randomized trial on altered-fractionated radiotherapy in nasopharyngeal carcinoma prematurely terminated by significant increase in neurologic complications. Int J Radiat Oncol Biol Phys 48 (2000) 1311-1322
28. Venkitaraman R., Ramanan S.G., and Sagar T.G. Nasopharyngeal cancer of childhood and adolescence: a single institution experience. Pediatr Hematol Oncol 24 (2007) 493-502
29. Wolden S.L., Chen W.C., Pfister D.G., Kraus D.H., Berry S.L., and Zelefsky M.J. Intensity-modulated radiation therapy (IMRT) for nasopharynx cancer: Update of the Memorial Sloan-Kettering experience. Int J Radiat Oncol Biol Phys 64 (2006) 57-62
30. Wolden S.L., Steinherz P.G., Kraus D.H., Zelefsky M.J., Pfister D.G., and Wollner N. Improved long-term survival with combined modality therapy for pediatric nasopharynx cancer. Int J Radiat Oncol Biol Phys 46 (2000) 859-864